Entries by merlin_admin

Roberta Angioni, U of Padova awarded for outstanding Bright Spark presentation at ECI meeting

MERLIN PhD student Roberta Angioni of the Università degli Studi di Padova was selected for a “Bright Spark” presentation during the 5th European Congress of Immunology (ECI). The ECI meeting was held in Amsterdam on September 2-5, 2018. Roberta remarks: “With my great pleasure, I was awarded with the “EFIS-Biolegend Bright Sparks Award for a presentation judged […]

Erasmus MC Mentor-Mentee team wins at Congress of the Transplantation Society

Erasmus Medical Center PhD student Jesus Sierra presented Merlin data at the Congress of the Transplantation Society in Madrid in July 2018. The title of Jesus’ talk was:  Monocytic cells phagocytose therapeutic mesenchymal stem cells, which induces polarization, relocation and immune regulation. Jesus Sierra in conjunction with Martin Hoogdujin, his mentor claimed the mentor-mentee award at […]

MERLIN publishes in Cytotherapy

The MERLIN study “Epigenetic changes in umbilical cord mesenchymal stromal cells upon stimulation and culture expansion” has been recently published in Cytotherapy The Journal of Cell Therapy. The body of research by Samantha F.H. de Witte1, Fleur S. Peters1, Ana Merino1, Sander S. Korevaar1, Joyce B.J. van Meurs2, Lisa O’Flynn3, Steve J. Elliman3, Philip N. Newsome4–6, […]

MERLIN trial attracts attention at Bioprocessing and Advanced Cellular Therapies Congress 2018

  Head of Process Development at Orbsen Therapeutics, Limited, Dr Lisa O’ Flynn attended the 3rd Annual Bioprocessing and Advanced Cellular Therapies Congress in Frankfurt, Germany. The meeting was held on the 29th-30th of May 2018. Lisa gave an oral presentation entitled ” CD362 to ORBCEL: the rapid development of a novel stromal cell therapy ” wherein […]

Roberta Angioni, University of Padua presents MERLIN at the Pediatric Research Institute meeting

Roberta Angioni of the Department of Biomedical Science at the University of Padua presented MERLIN’s objectives and results during  an invited talk entitled “Mesenchymal stem cells and their extracellular vesicles in the control of pathological angiogenesis” at the Pediatric Research Institute (IRP) meeting held April 7, 2018, at the Villa Pace Park Hotel, Preganziol in Treviso, Italy. Roberta […]

Merlin Newsletter Winter 2017 – 2018

The Merlin Newsletter for Winter 2017 – 2018 has just been issued! This is the second edition of our newsletter and includes the following sections: Refresher Course – a reminder of the project’s key aims and objectives Forging Ahead – a brief update on recent progress Read All About it – details of some of […]

Merlin team meet in Padua

The Merlin partners met in Padua on 22 and 23 January for our most recent plenary. The team heard updates from workstreams across the project and discussed the reports to be submitted to the EU by the end of January. MSC manufacture and plans for the clinical trial were also a key focus. An exploitation […]

S. de Witte, Erasmus MC presents MERLIN findings in 2017

S. de Witte of Erasmus University Medical Center in Rotterdam took to the road in 2017 to present MERLIN results at five conferences in Belgium, The Netherlands and Spain: · Erasmus MC, Science days of the Department of Internal Medicine, Antwerp Poster: IMPACT OF CULTURE EXPANSION AND INFLAMMATORY CYTOKINE CHALLENGE ON DNA METHYLATION PROFILES IN MSC […]

MERLIN will present at EU-MSC2 meeting in Leiden in September

Hosted by Leiden University Medical Center, the EU MSC2 2017 meeting in Leiden, NL on September 12th and 13th will assemble twelve EU-funded, mesenchymal stromal cell-focussed consortia. Projects to be presented include: REDDSTAR, REACH, RETHRIM, Stellar, MERLIN, Nephstrom, SCIENCE, VISICORT and Adipoa-2, AUTOSTEM, BOOSTB4, SEPCELL, RESSTORE, and RESPINE. This two day, interactive meeting will be held at the Stadsgehoorzaal Leiden. Three overarching aspects of the EU-MSC2 meeting include: mechanisms of action and […]